JP4514791B2 - 肝線維症の診断方法 - Google Patents
肝線維症の診断方法 Download PDFInfo
- Publication number
- JP4514791B2 JP4514791B2 JP2007525264A JP2007525264A JP4514791B2 JP 4514791 B2 JP4514791 B2 JP 4514791B2 JP 2007525264 A JP2007525264 A JP 2007525264A JP 2007525264 A JP2007525264 A JP 2007525264A JP 4514791 B2 JP4514791 B2 JP 4514791B2
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- liver
- sample
- ferritin
- timp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
b) 前記サンプル中のTIMP-1(メタロプロテイナーゼIの組織阻害剤)を測定する
c) 前記サンプル中のフェリチンを測定する
d) 前記サンプル中のA2M(α‐2‐マクログロブリン)およびPI(プロトロンビン指数)から成る群から選択される少なくとも1種の付加的なパラメーターを測定する
e) 場合により、前記サンプル中の少なくとも1つの付加的な生化学的または臨床的パラメーターを測定する
f) TIMP-1、フェリチンならびに段階d)および段階e)に従い測定したパラメーターの存在または測定レベルに基づいて肝疾患の存在および/または重症度を診断する。
Claims (2)
- 患者の肝線維症の存在および/または重症度を検出する方法であって:
a) 該患者からのサンプル中のTIMP-1(メタロプロテイナーゼIの組織阻害剤)を測定する
b) 前記サンプル中のフェリチンを測定する
c) 前記サンプル中のA2M(α‐2‐マクログロブリン)およびPI(プロトロンビン指数)から成る群から選択される少なくとも1種の付加的なパラメーターを測定する
d) 場合により、前記サンプル中の少なくとも1つの付加的な生化学的もしくは臨床的パラメーターを測定する
e) TIMP-1、フェリチンならびに段階c)および段階d)に従い測定したパラメーターの存在または測定レベルに基づいて肝疾患の存在および/または重症度を判定する;
ことを含む、前記方法。 - 肝線維症の治療処置をモニタリングするために使用される、請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04019133 | 2004-08-12 | ||
EP04025615A EP1626279B1 (en) | 2004-08-12 | 2004-10-28 | Method for diagnosing liver fibrosis |
PCT/EP2005/008777 WO2006015873A1 (en) | 2004-08-12 | 2005-08-12 | Method for diagnosing liver fibrosis |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008509410A JP2008509410A (ja) | 2008-03-27 |
JP4514791B2 true JP4514791B2 (ja) | 2010-07-28 |
Family
ID=35064736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007525264A Expired - Fee Related JP4514791B2 (ja) | 2004-08-12 | 2005-08-12 | 肝線維症の診断方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070178442A1 (ja) |
EP (1) | EP1626279B1 (ja) |
JP (1) | JP4514791B2 (ja) |
CA (1) | CA2575405C (ja) |
ES (1) | ES2303925T3 (ja) |
WO (1) | WO2006015873A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2457243T3 (es) * | 2006-09-08 | 2014-04-25 | The Chancellor, Masters And Scholars Of The University Of Oxford | Diagnóstico clínico de una fibrosis hepática utilizando APOL1 de suero humano como biomarcador |
EP2209003A1 (en) * | 2009-01-16 | 2010-07-21 | F. Hoffmann-Roche AG | Means and methods for differentiating between fibrosis and cirrhosis |
ES2683631T3 (es) * | 2009-02-26 | 2018-09-27 | Université d'Angers | Mejora de diagnóstico en la fibrosis o cirrosis hepática |
CA2761692A1 (en) * | 2009-05-14 | 2010-11-25 | Raymond A. Dwek | Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers |
DE102009040879B4 (de) * | 2009-09-09 | 2012-12-06 | Andreas Hettich Gmbh & Co. Kg | Verfahren zur Bestimmung der Gerinnungszeit |
EP2327988A1 (en) | 2009-11-28 | 2011-06-01 | Assistance Publique Hôpitaux De Paris | Method for diagnosis of fibrotic diseases |
US9140686B2 (en) | 2010-06-10 | 2015-09-22 | Metanomics Health Gmbh | Biomarkers for diagnosing liver disease |
JP5636567B2 (ja) * | 2010-10-13 | 2014-12-10 | 学校法人東京女子医科大学 | 脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体 |
MX2015012778A (es) * | 2013-03-15 | 2016-01-20 | Intermune Inc | Marcadores proteomicos de fibrosis pulmonar idiopatica (fpi). |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0823558B2 (ja) * | 1984-11-27 | 1996-03-06 | オ−ジエニクス リミテツド | 検定装置 |
JPS625999A (ja) * | 1985-07-02 | 1987-01-12 | Supeshiaru Refuarensu Lab:Kk | フエリチンに対する新規なモノクロ−ナル抗体 |
GB8803000D0 (en) * | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
ES2112916T3 (es) * | 1991-10-15 | 1998-04-16 | Multilyte Ltd | Ensayo de union que utiliza un reactivo marcado. |
DE19731465A1 (de) * | 1997-07-22 | 1999-01-28 | Boehringer Mannheim Gmbh | Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren |
RU2132071C1 (ru) * | 1998-04-21 | 1999-06-20 | Нижегородская государственная медицинская академия | Способ оценки степени повреждения печени |
EP1150123B1 (en) * | 2000-04-28 | 2006-07-12 | Bayer Aktiengesellschaft | Diagnosis of liver fibrosis with serum marker algorithms |
JP2002060345A (ja) * | 2000-08-21 | 2002-02-26 | Mochida Pharmaceut Co Ltd | 血液凝固能異常に係わる疾患の予防・治療剤 |
US6631330B1 (en) * | 2000-08-21 | 2003-10-07 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers |
IL154566A0 (en) * | 2000-08-21 | 2003-09-17 | Assist Publ Hopitaux De Paris | Diagnosis method of fibrotic disease using biochemical markers |
US6986995B2 (en) * | 2002-02-28 | 2006-01-17 | Prometheus Laboratories, Inc. | Methods of diagnosing liver fibrosis |
-
2004
- 2004-10-28 EP EP04025615A patent/EP1626279B1/en not_active Not-in-force
- 2004-10-28 ES ES04025615T patent/ES2303925T3/es active Active
-
2005
- 2005-08-12 JP JP2007525264A patent/JP4514791B2/ja not_active Expired - Fee Related
- 2005-08-12 WO PCT/EP2005/008777 patent/WO2006015873A1/en active Application Filing
- 2005-08-12 CA CA2575405A patent/CA2575405C/en not_active Expired - Fee Related
-
2007
- 2007-02-09 US US11/673,058 patent/US20070178442A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008509410A (ja) | 2008-03-27 |
EP1626279A1 (en) | 2006-02-15 |
CA2575405A1 (en) | 2006-02-16 |
WO2006015873A1 (en) | 2006-02-16 |
ES2303925T3 (es) | 2008-09-01 |
CA2575405C (en) | 2010-07-06 |
EP1626279B1 (en) | 2008-04-16 |
US20070178442A1 (en) | 2007-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4516124B2 (ja) | 肝線維症の診断方法 | |
JP4514791B2 (ja) | 肝線維症の診断方法 | |
US20200033367A1 (en) | Galectin-3 immunoassay | |
EP2281203B1 (en) | A marker for graft failure and mortality | |
JP5714019B2 (ja) | 急性心不全の診断、予知及び/又は予後用バイオマーカー及びその使用 | |
US20120022793A1 (en) | Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population | |
JP2011516874A (ja) | 最大酸素消費量低下の予測のためのプロ−エンドセリン−1 | |
JP2008102129A (ja) | 急性肺塞栓症用生化学マーカー | |
US20140120174A1 (en) | Methods of prognosis and diagnosis of sepsis | |
JP5746978B2 (ja) | 急性心不全の診断、予知及び/又は予後用バイオマーカー及びその使用 | |
US10996228B2 (en) | Biomarkers for assessment of preeclampsia | |
CN115015538A (zh) | 一种抗磷脂抗体检测试剂盒及其在系统性红斑狼疮肾炎检测中的应用 | |
CN116413430B (zh) | 一种用于肝癌早期预测的自身抗体/抗原组合及检测试剂盒 | |
DE602004013142T2 (de) | Verfahren zur Diagnose von Leberfibrose | |
CN117031042B (zh) | 用于筛查诊断先天性心脏病胎儿的生物标志物及其应用 | |
JP5663494B2 (ja) | 尿検体中のサブスタンスpの測定方法 | |
JP2023046810A (ja) | フォンタン術後の肝線維症の検出方法及び診断薬 | |
JP2013064616A (ja) | 高度動脈硬化を発症している可能性を検出する方法およびその利用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100105 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100405 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100427 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100511 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130521 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |